Zhiyi Jing Selected Research

sodium-bile acid cotransporter

1/2018	Silencing Retinoid X Receptor Alpha Expression Enhances Early-Stage Hepatitis B Virus Infection In Cell Cultures.
1/2018	The p.Ser267Phe variant of sodium taurocholate cotransporting polypeptide (NTCP) supports HBV infection with a low efficiency.
1/2017	Woodchuck sodium taurocholate cotransporting polypeptide supports low-level hepatitis B and D virus entry.
3/2014	Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide.
7/2013	Molecular determinants of hepatitis B and D virus entry restriction in mouse sodium taurocholate cotransporting polypeptide.
6/2013	Sodium taurocholate cotransporting polypeptide mediates woolly monkey hepatitis B virus infection of Tupaia hepatocytes.
11/2012	Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus.
11/2012	Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhiyi Jing Research Topics

Disease

7	Hepatitis B 01/2018 - 11/2012
7	Infections 01/2018 - 06/2013
6	Virus Diseases (Viral Diseases) 01/2018 - 11/2012
1	Triple Negative Breast Neoplasms 12/2021
1	Breast Neoplasms (Breast Cancer) 12/2021
1	Neoplasms (Cancer) 12/2021
1	Hepatitis D 04/2015
1	Severe Fever with Thrombocytopenia Syndrome 01/2014
1	Spinocerebellar Ataxia 10 09/2011

Drug/Important Bio-Agent (IBA)

8	sodium-bile acid cotransporterIBA 01/2018 - 11/2012
4	Taurocholic Acid (Sodium Taurocholate)IBA 01/2018 - 07/2013
3	RNA (Ribonucleic Acid)IBA 12/2021 - 04/2015
3	Antiviral Agents (Antivirals)IBA 04/2015 - 01/2014
3	Amino Acids FDA Link 07/2013 - 11/2012
2	Proteins (Proteins, Gene)FDA Link 04/2015 - 07/2013
2	Peptides (Polypeptides)IBA 04/2015 - 06/2013
1	Antigen Receptors (Antigen Receptor)IBA 12/2021
1	Circular DNAIBA 01/2018
1	Group II Phospholipases A2IBA 01/2018
1	Viral AntigensIBA 01/2018
1	Bexarotene (LGD1069)FDA Link 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	EicosanoidsIBA 01/2018
1	Arachidonic Acid (Vitamin F)IBA 01/2018
1	Retinoid X Receptor alphaIBA 01/2018
1	EnzymesIBA 01/2018
1	Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA 04/2015
1	AntibodiesIBA 04/2015
1	Hepatitis delta Antigens (HDAg)IBA 04/2015
1	SodiumIBA 03/2014
1	Pharmaceutical PreparationsIBA 03/2014
1	Bile Acids and Salts (Bile Acids)IBA 03/2014
1	Small Interfering RNA (siRNA)IBA 01/2014
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 01/2014
1	Immunoglobulin Fc FragmentsIBA 01/2014
1	Ataxin-10IBA 09/2011

Therapy/Procedure

3	Therapeutics 01/2018 - 03/2014
1	Immunotherapy 12/2021